BRAF and neoplasm: In cohort 1, FFPE tumour biopsies from 127 Danish MM patients, previously analyzed by the Cobas® 4800 BRAF V600 Mutation Test were retrospectively analyzed by the SensiScreen® FFPE BRAF qPCR Simplex and Multiplex assays.